Potential Benefits of Metformin Via Roseburia Intestinalis in High-fat Diet-fed Mice With Colorectal Adenomas
- 26 November 2025
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 18 (4) , 5818-5837
Abstract
Metformin (Met) is a pharmaceutical agent for the treatment of type 2 diabetes mellitus. Intriguingly, it may also play a role in the gastrointestinal tract, the gut microbial communities, and the tissue-resident immune cells. The present study aimed to investigate whether the administration of Met achieved protective effects on high-fat diet (HFD)-fed mice with colorectal adenomas (CRA) and elucidated its mechanism via the gut microbiota. AOM/DSS was administered in an HFD-induced diet to induce CRA in mice. 16 S rRNA sequencing was conducted to analyze the gut microbiota profile of mice. Met reduced the inflammatory response in the intestine and alleviated HFD-induced intestinal flora disturbances, and Roseburia intestinalis (R. intestinalis) colonization enhanced the efficacy of Met. Met suppressed CRA cell proliferation, which was further reduced by R. intestinalis. Met blocked NF-κB signaling by activating GILZ through increased R. intestinalis abundance. GILZ deletion in macrophages weakened the inhibition of CRA growth by Met and R. intestinalis, leading to increased macrophage M1 polarization. Inhibition of the NF-κB signaling reversed the activation of macrophage M1 polarization by knockdown of GILZ and reduced the proliferation of CRA cells. Our results shed light on the impact of Met on gut microbiome alteration in treating CRA.Keywords
Funding Information
- Nanjing Science and Technology Plan Project (202110014)
- Jiangsu Science and Technology Project (BE2022704)
This publication has 44 references indexed in Scilit:
- GILZ in sepsis: “Poor is the pupil who does not surpass his master”European Journal of Immunology, 2020
- Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell ActivationFrontiers in Immunology, 2019
- Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune responseMolecular Medicine Reports, 2019
- Amplified Host Defense by Toll-Like Receptor-Mediated Downregulation of the Glucocorticoid-Induced Leucine Zipper (GILZ) in MacrophagesFrontiers in Immunology, 2019
- Metformin protects against intestinal barrier dysfunction via AMPKα1‐dependent inhibition of JNK signalling activationJournal of Cellular and Molecular Medicine, 2017
- Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesityJournal of Lipid Research, 2016
- Obesity and metabolic syndrome: pathological effects on the gastrointestinal tractHistopathology, 2016
- NF‐κB1, NF‐κB2 and c‐Rel differentially regulate susceptibility to colitis‐associated adenoma development in C57BL/6 miceThe Journal of Pathology, 2015
- Obesity and colorectal cancer: Role of adipokines in tumor initiation and progressionWorld Journal of Gastroenterology, 2014
- The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patientsInternational Journal of Cancer, 1984